Posts by tag
CancerWorld
Daraxonrasib: A Turning Point for Pancreatic Cancer
Pancreatic ductal adenocarcinoma remains one of the most difficult cancers to treat, with limited progress in drug development over the past decade. At the 2026 ASCO Annual Meeting, the Phase 3 RASolute 302 trial delivered results that stood out against…
Doctor of Hope
How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…
Larry Leksell: The story of Elekta
“Tax planning was one major reason for the foundation of Elekta.” Larry Leksell says it with a smile that suggests he enjoys disrupting the mythology people create around founders. Most people expect a grand story of origin. A visionary revelation.…
CancerWorld #117 (July 2026)
We often describe progress in oncology through the language of innovation. New drugs. New technologies. New discoveries. Yet scientific breakthroughs rarely change cancer care on their own. They require people willing to pursue difficult ideas, build institutions, challenge accepted thinking,…
The Ovation and the Asterisk
Five trials, five cancers, and what the ASCO 2026 plenary really promised patients ASCO 2026’s plenary delivered five real advances across five cancers, and a standing ovation that pulled a hall full of oncologists to their feet. The harder question…
Between Theory and Bedside: What Early Palliative Care in Singapore Reveals About Cancer, Care, and the Limits of Knowledge
On paper, cancer care can be mapped, measured, and modelled. In practice, it is far less contained. For Charis Ng, a trainee health psychologist and PhD student, that gap between theory and lived reality became impossible to ignore during her…
The Right to Be Forgotten: Why Voluntary Measures are Not Enough for Cancer Survivors
On World Cancer Day, Commissioners Várhelyi and Albuquerque reaffirmed the European Commission’s commitment to the right to be forgotten for cancer survivors. Yet their announcement of non-binding guidance to financial institutions in 2026 falls significantly short of what survivors and…
Building Beyond the Bedside: Dr Mohamed Emam Sobeih’s Vision for the Future of Oncology
From crowded oncology wards in Cairo to international leadership in cancer education, Dr. Mohamed Emam Sobeih has built a career shaped by one central belief: treating cancer requires more than medicine alone. At the National Cancer Institute Egypt, where Dr…
European Cancer Nursing Day 2026: Supporting Life Beyond Cancer
Europe-wide online event highlights survivorship, innovation, education, advocacy, and the future of cancer nursing On 18 May 2026, the European Oncology Nursing Society (EONS) marked European Cancer Nursing Day (ECND26) with an online Europe-wide celebration bringing together cancer nurses under…
Oncologists Urged to Have Open Discussion about CAM Use with Patients
CAM use linked to higher mortality in breast cancer patients A cohort study of women with breast cancer has shown that use of complementary and alternative medicine (CAM) in association with traditional therapies was associated with higher mortality compared with…